See inside every stock. Pro
S&P 5007,663▼ 1.21%Nasdaq26,009▼ 2.60%Dow Jones52,868▲ 0.02%Nasdaq 10028,959▼ 2.90%VIX19.03▲ 14.09%US Dollar101.62▼ 0.16%Gold spot4,093▼ 0.80%WTI100.23▲ 0.76%
Copenhagen Exchange · Denmark · Updated after 22 Oct 2026 close

Bavarian Nordic

BAVA · Copenhagen Exchange · prices in DKK
DKK 245.00▲ +1.20 (0.49%)
Research reportHistorical data

About Bavarian Nordic

Bavarian Nordic is a Danish vaccine company that develops and manufactures vaccines for infectious diseases. Its products include vaccines against smallpox and mpox, as well as travel vaccines and other immunisation products. The company serves public health authorities, governments and healthcare providers, with its operations based in Denmark and manufacturing and research activities in Europe and North America. It works on both marketed vaccines and development programmes for diseases with limited treatment options.

The shares are listed on the Copenhagen Exchange in Denmark under the code BAVA, and the price on this page is in Danish kroner (DKK). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

71/ 100
Market X-Ray · price-based
Strong price profile
Ranks #33 of 164 on the Copenhagen Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Denmark yet.
TrendStrong
91/100
Trading above its long-term averages and near its highs.
See the numbers →
Above 200-day average25.3%
From 52-week high0.0%
MomentumStrong
71/100
Rising faster than most stocks on this exchange.
See the numbers →
3-month return36.1%
6-month return27.4%
12-month, skipping last month-11.7%
Stability (higher is calmer)Weak
42/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)34.8%
Worst drawdown, 1 year (smaller is calmer)-28.7%
LiquidityStrong
84/100
Trades actively.
See the numbers →
Avg daily value traded43.37M DKK
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Denmark when fundamentals data for this market is added. All Denmark stocks.
Price trend
Uptrend
Versus its 50- and 200-day averages
52-week range
171.30 – 245.40
Price is 99% of the way up
Returns
+36.1% 3m · +1.3% 1y
Price returns, dividends not included
RSI (14)
73
Overbought zone

Price chart

52-wk range 171.30 – 245.40 Daily closes, split-adjusted

Signals

50-day average216.82
200-day average195.60
Golden/death cross (60d)Golden, 33 days ago
New 52-week highYes
Bullish RSI divergenceNo
Average daily range (ATR)5.22

Technical summary

Daily
Bullish
12 bullish · 0 neutral · 4 bearish
Weekly
Strongly bullish
11 bullish · 0 neutral · 1 bearish
Monthly
Strongly bullish
7 bullish · 1 neutral · 0 bearish
Moving averages (daily)
SMA 10239.4Bullish
EMA 10238.2Bullish
SMA 20230.1Bullish
EMA 20231.6Bullish
SMA 50216.8Bullish
EMA 50218.2Bullish
SMA 100198.9Bullish
EMA 100207.4Bullish
SMA 200195.6Bullish
EMA 200201.1Bullish
Oscillators (daily)
RSI (14)73.19Bearish
MACD (12, 26)8.45Bullish
Momentum (12)10.56Bullish
Stochastic %K (14)98.54Bearish
Williams %R (14)-1.46Bearish
CCI (20)101.5Bearish
Pivot points (classic, last session)
S3
238.7
S2
239.9
S1
242.5
Pivot
243.7
R1
246.3
R2
247.5
R3
250.1
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.

Prices are end-of-day closes in DKK. Educational only, not financial advice.